Patricia Le Saëc

Patricia Le Saëc

Auto-generated profile, based on publicly available information

Patricia Le Saëc

Univ. Angers, Nantes Univ., Inserm, CNRS, CRCI2NA, CHU Nantes F‐44007 Nantes France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
MFMathieu Frindel
Mathieu Frindel
PSPatricia Le Saëc
Patricia Le Saëc
MBMaryline Beyler
Maryline Beyler
ANAnne-Sophie Navarro
Anne-Sophie Navarro
CSCatherine Saï-Maurel
Catherine Saï-Maurel
RTRaphael Tripier
Raphael Tripier
Te1pa conjugated to an F6 antibody was confirmed to be an interesting alternative to dota for64Cuin vivoPET imaging.

24 June 2014 in Chempluschem
Verified
Journal Article
Closed access
PDF file
EBEwen Bodio
Ewen Bodio
MBMohammed Boujtita
Mohammed Boujtita
KJKarine Julienne
Karine Julienne
PSPatricia Le Saec
Patricia Le Saec
SGSébastien G. Gouin
Sébastien G. Gouin
DDDavid Deniaud
David Deniaud

21 December 2022 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JPJulie Pineau
Julie Pineau
LLLuís M. P. Lima
Luís M. P. Lima
MRMarie M. Le Roy
Marie M. Le Roy
SLSéverine Lambot
Séverine Lambot
MCMarie Cordier
Marie Cordier
RTRaphael Tripier
Raphael Tripier
Two bifunctional copper chelators H 2 TE1PA-trz-prA and H 2 CB-TE1PA-trz-prA were synthesized and their relevant nat Cu- and 64 Cu-complex properties highlighted.

14 June 2025 in ChemMedChem
Verified
Journal Article
Open access
MRMarie M. Le Roy
Marie M. Le Roy
PSPatricia Le Saëc
Patricia Le Saëc
MCMichel Chérel
Michel Chérel
AFAlain Faivre‐Chauvet
Alain Faivre‐Chauvet
TTThibault Troadec
Thibault Troadec
RTRaphael Tripier
Raphael Tripier
CXCR4 is a transmembrane receptor overexpressed in a large variety of cancer cells. In addition to classical antibody‐ and peptide‐targeting for the development of positron emission tomography (PET) radiopharmaceuticals, this receptor possesses a range of small organic inhibitors that can be exploited. These are based mainly on nitrogen‐rich scaffolds, such as AMD070, and cyclic polyamines, such as cyclam, in the AMD3100 skeleton. The latter has been explored as a direct 64Cu chelator, but examples of CXCR4 PET imaging with small organic targeting units are still scarce in the literature. Herein, the synthesis of two novel CXCR4‐directed radiopharmaceuticals is described, combining the AMD070 scaffold as a targeting unit and bifunctional te1pa macrocycle as a strong 64Cu chelator. The synthesis of the conjugates and optimization of 64Cu‐radiolabeling are presented, opening the way for future in vitro and in vivo studies.

1 December 2020 in ChemRxiv
Verified
Preprint
Open access
RKRichard Knighton
Richard Knighton
TTThibault Troadec
Thibault Troadec
VMValérie Mazan
Valérie Mazan
PSPatricia La Saëc
Patricia La Saëc
SLSéverine Lambot
Séverine Lambot
RTRaphael Tripier
Raphael Tripier
Herein we present the preparation of two novel cyclam-based macrocycles (te1pyp and cb-te1pyp), bearing phosphonate-appended pyridine side-arms for the coordination of copper(II) ions in the context of 64Cu PET imaging. The two ligands have been prepared through conventional protection-alkylation sequences on cyclam, and their coordination properties have been thoroughly investigated. The corresponding copper complexes have been fully characterized in the solid-state (X-Ray diffraction analysis) and in solution (EPR and UV-Vis spectroscopies). Potentiometric studies, combined with spectrometry, have also allowed us to determine their thermodynamic stability constants, confirming their high affinity for copper(II) cations. The kinetic inertness of the complexes has also been verified by acid-assisted dissociation experiments, enabling their use in 64Cu-PET imaging in mice for the first time. Indeed, the two ligands could be quantitatively radiolabeled under mild conditions, and the resulting 64Cu complexes have demonstrated excellent stability in serum. PET imaging demon-strated a set of features emerging from the combination of picolinates and phosphonate units: high stability in vivo, fast clear-ance from the body via renal elimination, and most interestingly, very low fixation in the liver. The latter is in contrast with what was observed for monopicolinate cyclam (te1pa), that had a non-negligible accumulation in the liver, owing probably to its different charge and lipophillicity. These results thus pave the way for the use of such phosphonated pyridine chelators for in vivo 64Cu-PET imaging.